Skip to content
10-Q

Quarterly Report

Minerva Neurosciences, Inc. NERV

0001193125-26-205182

← back to feed
Filed
May 5, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 46.59M sh
Shares Diluted Q1 2026 · Mar 31, 2026 43.9M sh
Shares Diluted Q1 2026 · Mar 31, 2025 7.57M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$5.43M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$4.07M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $32.66M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $82.3M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $17.29M
Stockholders Equity Q1 2026 · Mar 31, 2026 −$254.01M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$140.75M
Stockholders Equity Q1 2026 · Mar 31, 2025 −$29.15M
Stockholders Equity Q1 2026 · Dec 31, 2024 −$25.69M
Current Liabilities Q1 2026 · Mar 31, 2026 $4.48M
Current Liabilities Q1 2026 · Dec 31, 2025 $2.29M
Total Liabilities Q1 2026 · Mar 31, 2026 $343.08M
Total Liabilities Q1 2026 · Dec 31, 2025 $233.76M
Current Assets Q1 2026 · Mar 31, 2026 $79.11M
Current Assets Q1 2026 · Dec 31, 2025 $83.1M
Total Assets Q1 2026 · Mar 31, 2026 $94.03M
Total Assets Q1 2026 · Dec 31, 2025 $97.97M
Eps Diluted Q1 2026 · Mar 31, 2026 −$2.86
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.50
Eps Basic Q1 2026 · Mar 31, 2026 −$2.86
Eps Basic Q1 2026 · Mar 31, 2025 −$0.50
Sga Expense Q1 2026 · Mar 31, 2026 $11.42M
Sga Expense Q1 2026 · Mar 31, 2025 $2.54M
Rd Expense Q1 2026 · Mar 31, 2026 $5.25M
Rd Expense Q1 2026 · Mar 31, 2025 $1.36M
Net Income Q1 2026 · Mar 31, 2026 −$125.4M
Net Income Q1 2026 · Mar 31, 2025 −$3.75M
Operating Income Q1 2026 · Mar 31, 2026 −$16.67M
Operating Income Q1 2026 · Mar 31, 2025 −$3.9M